Articles Referencing CYBX
Earnings Beat for ABAX, Sluggish Overall - Analyst Blog
4/26/2013, 4:00 pm from Zacks.com in Investing, Business, Earnings, Stocks
Provider of portable blood analysis systems for human and
veterinary patient-care, Abaxis Inc. ( ABAX ) reported
fourth-quarter fiscal 2013 earnings per share ("EPS") of 30... Read >>
PerkinElmer Misses Earnings and Rev Est - Analyst Blog
4/26/2013, 9:22 am from Zacks.com in Investing, Business, Earnings, Stocks
PerkinElmer ( PKI ) reported
first-quarter adjusted (excluding one-time expenses) earnings per
share of 36 cents, missing the Zacks Consensus Estimate of 48 cents
and lower than the... Read >>
BSX Beats Y/Y Earnings, Guides Low - Analyst Blog
4/25/2013, 4:12 pm from Zacks.com in Investing, Business, Earnings, Stocks
Boston Scientific ( BSX ) reported adjusted
earnings per share (after considering certain adjustments other
than amortization expense) ("EPS") of 10 cents in the first quarter
of... Read >>
OCR Beats on Earnings Est; Misses Rev - Analyst Blog
4/25/2013, 3:13 pm from Zacks.com in Investing, Business, Earnings, Stocks
Provider of drugs to long-term care facilities and nursing
homes, Omnicare Inc. ( OCR ) posted first
quarter 2013 adjusted (excluding one-time expenses) earnings per
share of 90 cents... Read >>
Varian Beats Earnings and Rev Est - Analyst Blog
4/25/2013, 2:09 pm from Zacks.com in Investing, Business, Earnings, Stocks
Varian Medical Systems ( VAR ) posted
second-quarter fiscal 2013 adjusted (excluding one-time items other
than stock based compensation expense) net earnings of $1.04 per
share beating the... Read >>
TMO's Earnings Beat, LIFE Buyout on Track - Analyst Blog
4/24/2013, 12:15 pm from Zacks.com in Investing, Business, Earnings, Stocks
Thermo Fisher Scientific ( TMO ) reported adjusted
earnings per share ("EPS") of $1.37 in the first quarter of fiscal
2013. This was 6.2% ahead of the Zacks Consensus Estimate of... Read >>
AmSurg's Rev and Earnings In Line - Analyst Blog
4/24/2013, 9:30 am from Zacks.com in Investing, Business, Earnings, Stocks
AmSurg Corp. 's ( AMSG ) first-quarter
2013 adjusted earnings per share ("EPS") of 52 cents were 2 cents
ahead of the year-ago quarter EPS and in line with the Zacks
Consensus... Read >>
Illumina Beats on Earnings, Revenue - Analyst Blog
4/23/2013, 3:11 pm from Zacks.com in Investing, Business, Earnings, Stocks
Illumina Inc.'s ( ILMN ) first-quarter
2013 adjusted earnings of 46 cents per share beat the Zacks
Consensus Estimate by 21%. Adjusted earnings grew almost 28% over
the prior-year quarter... Read >>
Varian to Work with PSI on IMPT - Analyst Blog
4/22/2013, 2:09 pm from Zacks.com in Investing, Business, Stocks
Oncology and X-Ray products company Varian Medical
Systems ( VAR ) and Paul Scherrer
Institute ("PSI") recently revealed a collaborative effort to
pursue further knowledge in... Read >>
Covidien Expands Shiley Offerings - Analyst Blog
4/19/2013, 3:50 pm from Zacks.com in Investing, Business, Stocks
International health care products major, Covidien
plc ( COV )
has expanded its portfolio of Shiley neonatal and pediatric
tracheostomy tubes with the launch of a new offering. The... Read >>
FDA Nod for Luminex Offering - Analyst Blog
4/19/2013, 2:10 pm from Zacks.com in Investing, Business, Stocks
Diagnostic testing technologies company, Luminex
Corporation ( LMNX ) has won
clearance from the U.S. Food and Drug Administration for its MAGPIX
instrument, with its xTAG Gastrointestinal... Read >>
Cepheid Earnings Beat, Retains Outlook - Analyst Blog
4/19/2013, 12:13 pm from Zacks.com in Investing, Business, Earnings, Stocks
Cepheid ( CPHD ) reported
first-quarter 2013 adjusted earnings of 2 cents per share,
significantly better than the Zacks Consensus Estimate of loss of 2
cents per share and loss of 10 cents... Read >>
LabCorp Earnings Misses Again - Analyst Blog
4/19/2013, 11:14 am from Zacks.com in Investing, Business, Earnings, Stocks
Laboratory Corporation of America Holdings ' (
LH ) first-quarter
2013 adjusted earnings per share of $1.74 remained flat on a
year-over-year basis but missed the Zacks Consensus Estimate... Read >>
Volcano Corporation Stays Neutral - Analyst Blog
4/18/2013, 3:12 pm from Zacks.com in Investing, Business, Stocks
Recently, we have reaffirmed our Neutral recommendation on
Volcano Corporation ( VOLC ). Although we
are concerned about the company's disappointing fourth quarter 2012
and conservative... Read >>
Myriad Downgraded to Neutral - Analyst Blog
4/18/2013, 3:10 pm from Zacks.com in Investing, Business, Stocks
On Apr 17, we downgraded our recommendation on Myriad
Genetics Inc. ( MYGN ) to Neutral from
Outperform. Despite the recent healthy growth, the stock is
presently out of favor on account of... Read >>